We draw on our parent company’s expertise in pharmaceutical development to provide custom development services for active pharmaceutical ingredients and intermediates. CPS’ two R&D facilities -- TDC 1 (Miyapur, India) and Chirotech (Cambridge, UK) supported by pilot plants in Mirfield (UK) and Hyderabad (India) develop scalable, robust and cost-effective chemical processes for your API including highly potent. In addition, our partners have access to our analytical laboratories and regulatory affairs team who can offer full regulatory filing support.

Why us:

  • We have an extensive knowledge from developing hundreds of complex pharmaceutical products
  • We rethink processes to ensure better quality in shorter timelines
  • We apply new science and technologies (e.g. flow chemistry) to reduce costs or risk and add innovation


For more information, please contact us on